• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.46% Nasdaq Up0.05%

    Cyclacel Pharmaceuticals, Inc. (CYCC)

    -NGM
    0.69 Up 0.01(0.98%) 11:46AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Cash FlowGet Cash Flow for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Net Income (10,153) (13,186) (15,243)
    Operating Activities, Cash Flows Provided By or Used In
    Depreciation70  60  241  
    Adjustments To Net Income(6,165)(446)274  
    Changes In Accounts Receivables -   -   -  
    Changes In Liabilities(750)1,768  577  
    Changes In Inventories -   -   -  
    Changes In Other Operating Activities(1,201)(239)174  
    Total Cash Flow From Operating Activities (18,199) (12,043) (13,977)
    Investing Activities, Cash Flows Provided By or Used In
    Capital Expenditures(208)(12)(6)
    Investments -   -   -  
    Other Cash flows from Investing Activities5,896  62  5  
    Total Cash Flows From Investing Activities 5,688   50   (1)
    Financing Activities, Cash Flows Provided By or Used In
    Dividends Paid(305) -  (364)
    Sale Purchase of Stock27,637  3,975  9,270  
    Net Borrowings -   -   -  
    Other Cash Flows from Financing Activities -   -   -  
    Total Cash Flows From Financing Activities 27,332   3,975   8,906  
    Effect Of Exchange Rate Changes(87)(19)26  
    Change In Cash and Cash Equivalents 14,734   (8,037) (5,046)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.